LEVEL FOUR ADVISORY SERVICES, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1696715 DALLAS, TX

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$691,512

-$43,308 QoQ

Shares Held

895

-6.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

LEVEL FOUR ADVISORY SERVICES, LLC holds $8,781,235 across 9 Biotechnology names. REGN ranks #5 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	9,524	$4,252,846
2	GMAB	Genmab A/S	57,023	$1,529,927
3	ARGX	Argenx SE	1,131	$825,912
4	CELC	Celcuity Inc.	6,417	$732,436
5	REGN	Regeneron Pharmaceuticals, Inc. This page	895	$691,512
6	JAZZ	Jazz Pharmaceuticals plc	3,471	$656,192
7	MNKD	Mannkind Corp	21,098	$51,690
8	OCGN	Ocugen, Inc.	17,000	$30,770

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$691,512	895	-6.0%	Shares	Sole	2026-05-14
2025-12-31	$734,820	952	+65.3%	Shares	Sole	2026-02-13
2023-09-30	$474,024	576	+21.0%	Shares	Sole	2023-11-13
2023-06-30	$342,025	476	+75.6%	Shares	Sole	2023-07-10
2023-03-31	$222,672	271	-8.1%	Shares	Sole	2023-06-05
2022-12-31	$212,839	295	+1.0%	Shares	Sole	2023-02-13
2022-09-30	$201,150	292	-18.2%	Shares	Sole	2022-11-07
2022-06-30	$211,033	357	-27.4%	Shares	Sole	2022-08-08
2022-03-31	$343,622	492	+32.3%	Shares	Sole	2022-05-10
2021-12-31	$234,925	372	-89.9%	Shares	Sole	2022-02-11
2021-06-30	$2,049,841	3,670	—	Shares	Sole	2021-08-09
No filing history on record for this holder in this stock.